<DOC>
	<DOC>NCT02389829</DOC>
	<brief_summary>Opioids are commonly used to treat migraine in North American Emergency Departments. We are comparing efficacy and adverse events of hydromorphone, an opioid, to that of prochlorperazine, a dopamine antagonist with known efficacy in migraine. Prochlorperazine will be combined with diphenhydramine to prevent adverse events.</brief_summary>
	<brief_title>Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Prochlorperazine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Migraine headache (International Classification of Headache Disorders 3B criteria) Brain imaging ordered Fever Objective neurological findings Pregnancy/ breast feeding Allergy/ contraindication to investigational medication History of addiction to opioids, use of methadone, any use of opioids previous 30 days</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>